Literature DB >> 17584530

Automated red cell exchange procedures in patients with sickle cell disease.

Ilknur Kozanoglu1, Can Boga, Hakan Ozdogu, Nurzen Sezgin, Ebru Kizilkilic, Mahmut Kural.   

Abstract

In automated red cell exchange, about 60% of the patient's red blood cells are exchanged via apheresis for those of the donor. We report the outcome of 83 patients with sickle cell anemia (48 women and 35 men; age range, 17-49 years) who underwent a total of 196 apheresis procedures between December 2003 and October 2006 at our institution. We found that automated red cell exchange involving a reduced citrate infusion rate may provide benefit in the prevention or treatment of vaso-occlusive complications in patients with sickle cell disease and may be associated with protean effects on biochemical dynamics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584530     DOI: 10.1016/j.transci.2007.03.012

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  3 in total

1.  Erythrocytapheresis: Do Not Forget a Useful Therapy!

Authors:  Heidrun Ullrich; Roland Fischer; Regine Grosse; Uwe Kordes; Claudia Schubert; Bettina Altstadt; Georges Andreu
Journal:  Transfus Med Hemother       Date:  2008-01-15       Impact factor: 3.747

2.  Comparative efficacy in red blood cell exchange transfusions with different apheresis machines in patients with sickle cell disease.

Authors:  Nurhilal Buyukkurt; Ilknur Kozanoğlu; Asli Pan Korur; Suheyl Asma; Mahmut Yeral; Soner Solmaz; Fatih Kandemir; Cigdem Gereklioglu; Cagla Sariturk; Can Boga; Hakan Ozdogu
Journal:  Indian J Hematol Blood Transfus       Date:  2017-11-07       Impact factor: 0.900

3.  Short-term central venous catheter complications in patients with sickle cell disease who undergo apheresis.

Authors:  Mahmut Yeral; Can Boga; Levent Oguzkurt; Suheyl Asma; Mutlu Kasar; Ilknur Kozanoglu
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.